Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 2, 2006, Pages 382-391

  Salama, Joseph K ^a   Vokes, Everett E ^a   Chmura, Steven J ^a   Milano, Michael T ^a   Kao, Johnny ^a   Stenson, Kirsten M ^a   Witt, Mary Ellyn ^a   Haraf, Daniel J ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Chemoradiotherapy; Head and neck cancer; Reirradiation

Indexed keywords

CELLS; PATIENT TREATMENT; SURGERY; SURGICAL EQUIPMENT; TOXICITY;

HEAD-AND-NECK CANCER; OVERALL SURVIVAL (OS); PROGRESSION-FREE SURVIVAL (PFS); REIRRADIATION;

CHEMOSTATS;

CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; HYDROXYUREA; IRINOTECAN; PACLITAXEL;

ADULT; AGED; ARTICLE; BLEEDING; BONE NECROSIS; CANCER CONTROL; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FATALITY; DYSPHAGIA; EPISTAXIS; FACE EDEMA; FEMALE; FISTULA; HEAD AND NECK CARCINOMA; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RESPIRATORY ARREST; SENSORY NEUROPATHY; SPEECH DISORDER; SPINAL CORD DISEASE; SQUAMOUS CELL CARCINOMA; TISSUE NECROSIS; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; CAMPTOTHECIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; HYDROXYUREA; MALE; MANDIBULAR DISEASES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; OSTEORADIONECROSIS; PACLITAXEL; PROGNOSIS; RADIOTHERAPY DOSAGE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 30544451541     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.07.005     Document Type: Article

References (44)

1. J.S. Cooper, T.F. Pajak, A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
2. J. Bernier, C. Domenge, M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952
3. A.A. Forastiere, H. Goepfert, M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
4. A. Forastiere, W. Koch, A. Trotti Head and neck cancer N Engl J Med 345 2001 1890 1900
5. B. Brockstein, E.E. Vokes Concurrent chemoradiotherapy for head and neck cancer Semin Oncol 31 2004 786 793
6. M.P. McLaughlin, J.T. Parsons, D.A. Fein Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx Head Neck 18 1996 229 235
7. L.Y. Wong, W.I. Wei, L.K. Lam Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery Head Neck 25 2003 953 959
8. J.T. Parsons, W.M. Mendenhall, S.P. Stringer Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx Int J Radiat Oncol Biol Phys 32 1995 605 609
9. S.R. Mabanta, W.M. Mendenhall, S.P. Stringer Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes Head Neck 21 1999 591 594
10. Liverpool Head and Neck Oncology Group A phase III randomised trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck Br J Cancer 61 1990 311 315
11. K.R. Stevens Jr, A. Britsch, W.T. Moss High-dose reirradiation of head and neck cancer with curative intent Int J Radiat Oncol Biol Phys 29 1994 687 698
12. C.C. Wang Re-irradiation of recurrent nasopharyngeal carcinoma - Treatment techniques and results Int J Radiat Oncol Biol Phys 13 1987 953 956
13. R.R. Weichselbaum, M.A. Beckett, J.L. Schwartz Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy Int J Radiat Oncol Biol Phys 15 1988 575 579
14. T.F. DeLaney, N. Afridi, A.G. Taghian 13-Cis-retinoic acid with alpha-2a-interferon enhances radiation cytotoxicity in head and neck squamous cell carcinoma in vitro Cancer Res 56 1996 2277 2280
15. E.E. Vokes, M. Beckett, T. Karrison The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines Oncology 49 1992 454 460
16. W.K. Hong, R. Bromer Chemotherapy in head and neck cancer N Engl J Med 308 1983 75 79
17. G.J. Richards Jr, R.G. Chambers Hydroxyurea A radiosensitizer in the treatment of neoplasms of the head and neck Am J Roentgenol Radium Ther Nucl Med 105 1969 555 565
18. T.C. Lo, A.L. Wiley Jr, F.J. Ansfield Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx A randomized study AJR Am J Roentgenol 126 1976 229 235
19. R.G. Moran, P.V. Danenberg, C. Heidelberger Therapeutic response of leukemic mice treated with fluorinated pyrimidines and inhibitors of deoxyuridylate synthesis Biochem Pharmacol 31 1982 2929 2935
20. O.S. Frankfurt Enhancement of the antitumor activity of 5-fluorouracil by drug combinations Cancer Res 33 1973 1043 1047
21. E.E. Vokes, W.R. Panje, R.L. Schilsky Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer A phase I-II study J Clin Oncol 7 1989 761 768
22. D.J. Haraf, R.R. Weichselbaum, E.E. Vokes Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer A potentially curable disease Ann Oncol 7 1996 913 918
23. B. Brockstein, D.J. Haraf, K. Stenson Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck J Clin Oncol 16 1998 735 744
24. E.E. Vokes, D.J. Haraf, R. Mick Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer J Clin Oncol 12 1994 2351 2359
25. B. Brockstein, D.J. Haraf, K. Stenson A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer Ann Oncol 11 2000 721 728
26. S.J. Chmura, E.E. Vokes, M. Garofalo Long-term outcome of re-irradiation with concomitant chemotherapy for locally recurrent squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 57 2003 S409 S410
27. J.K. Salama, D.J. Haraf, K. Stenson Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer Toxicity and outcome results Cancer J 11 2005 140 146
28. M.T. Milano, D.J. Haraf, K.M. Stenson Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck Clin Cancer Res 10 2004 4922 4932
29. R. De Crevoisier, C. Domenge, P. Wibault Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma Cancer 91 2001 2071 2076
30. R. De Crevoisier, J. Bourhis, C. Domenge Full-dose reirradiation for unresectable head and neck carcinoma Experience at the Gustave-Roussy Institute in a series of 169 patients J Clin Oncol 16 1998 3556 3562
31. S.A. Spencer, J. Harris, R.H. Wheeler RTOG 96-10 Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck Int J Radiat Oncol Biol Phys 51 2001 1299 1304
32. S.A. Spencer, R.H. Wheeler, G.E. Peters Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck Am J Clin Oncol 22 1999 1 5
33. D.J. Haraf, E.E. Vokes, R.R. Weichselbaum Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil, and hydroxyurea in poor-prognosis head and neck cancer Laryngoscope 102 1992 630 636
34. M.T. Milano, E.E. Vokes, K.M. Stenson Twice-daily re-irradiation of recurrent and second primary head and neck cancer with gemcitabine, paclitaxel, and fluorouracil chemoradiotherapy J Clin Oncol 22 2004
35. M.T. Milano, E.E. Vokes, J.K. Salama Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy Int J Radiat Oncol Biol Phys 61 2005 1096 1106
36. D. Haraf, T. Chung, K. Stenson High dose reirradiation with concomitant chemotherapy for local/regionally recurrent head and neck cancer (HNC) Results in 48 patients [Abstract] Proc Am Soc Clin Oncol 19 2000 413a
37. J. Kao, M.C. Garofalo, M.T. Milano Reirradiation of recurrent and second primary head and neck malignancies A comprehensive review Cancer Treat Rev 29 2003 21 30
38. M. Machtay, D.I. Rosenthal, A.A. Chalian Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer Int J Radiat Oncol Biol Phys 59 2004 72 77
39. S. Spencer, R. Wheeler, G. Peters Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer Head Neck 25 2003 118 122
40. U. Schaefer, O. Micke, P. Schueller Recurrent head and neck cancer Retreatment of previously irradiated areas with combined chemotherapy and radiation therapy - Results of a prospective study Radiology 216 2000 371 376
41. N.R. Datta, Y.S. Nagar, S. Singh Loco-regional failures in head and neck cancer Can they be effectively salvaged by nonsurgical therapeutic modalities? Int J Clin Oncol 8 2003 31 39
42. C.J. Langer Phase II trial of concurrent split course hyperfractionated radiotherapy (HFX RT), cisplatin (DDP), and paclitaxel (P) in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck (SCCHN) Results of RTOG 9911 J Clin Oncol 22 Suppl 2004 5509 No. 14S, July 15, 2004
43. K.K. Fu, T.F. Pajak, A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
44. A.G. Maran, M. Amin, J.A. Wilson Radical neck dissection A 19-year experience J Laryngol Otol 103 1989 760 764